DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Cudkowicz ME, van den Berg LH, Shefner JM. et al
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
The Lancet Neurology 2013;
12: 1059-1067
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.